|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
EPY0001071 |
European Pharmacopoeia |
Benserazide impurity C CRS 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001072 |
European Pharmacopoeia |
Losartan impurity D 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001073 |
European Pharmacopoeia |
Beclometasone dipropionate impurities F and N 0.052mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001074 |
European Pharmacopoeia |
Rifaximin 160mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001075 |
European Pharmacopoeia |
Rifaximin for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001076 |
European Pharmacopoeia |
Losartan for system suitability 0.0015mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001077 |
European Pharmacopoeia |
Iopromide impurity A 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- dicarboxamide TBC |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001078 |
European Pharmacopoeia |
Bicisate labelling kit TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001080 |
European Pharmacopoeia |
Meloxicam 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001081 |
European Pharmacopoeia |
Mefenamic acid impurity A 2,3-dimethylaniline 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001082 |
European Pharmacopoeia |
Fluvastatin for system suitability 0.5mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001083 |
European Pharmacopoeia |
Methyldopa for system suitability 0.024mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001084 |
European Pharmacopoeia |
Acetazolamide for system suitability 0.0068mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001085 |
European Pharmacopoeia |
Lamotrigine for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001086 |
European Pharmacopoeia |
Mebrofenin TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001087 |
European Pharmacopoeia |
Tetra-O-acetyl-mannose triflate *** 80mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001088 |
European Pharmacopoeia |
Cyclopentolate for system suitability 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001089 |
European Pharmacopoeia |
Atenolol for system suitability 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001090 |
European Pharmacopoeia |
Fluvastatin sodium 110mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001091 |
European Pharmacopoeia |
Standardised artichoke leaf dry extract 60mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001092 |
European Pharmacopoeia |
Hydrocortisone Peak Identification 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001093 |
European Pharmacopoeia |
Vedaprofen 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001094 |
European Pharmacopoeia |
Aceclofenac for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001095 |
European Pharmacopoeia |
Cyproheptadine impurity C 5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001096 |
European Pharmacopoeia |
Valaciclovir impurity D 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001097 |
European Pharmacopoeia |
Valaciclovir impurity E 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001098 |
European Pharmacopoeia |
Valaciclovir impurity F para-toluenesulfonate 2-hydroxyethyl L-valinate 12mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001099 |
European Pharmacopoeia |
Valaciclovir impurity G N,N-dimethylpyridin-4-amine 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001100 |
European Pharmacopoeia |
Itraconazole for system suitability 25mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001101 |
European Pharmacopoeia |
Interferon beta-1a *** 0.6ml |
|
182.24 CHF
198.09 €
|
|
|
|
EPY0001102 |
European Pharmacopoeia |
Teicoplanin 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001103 |
European Pharmacopoeia |
Dimenhydrinate for peak identification 1mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001104 |
European Pharmacopoeia |
Picosulfate for system suitability 0.5mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001105 |
European Pharmacopoeia |
Drospirenone 80mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001106 |
European Pharmacopoeia |
Medronic acid impurity B Tetrakis(1-methylethyl)methhylenediphosphonate TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001107 |
European Pharmacopoeia |
Medronic acid impurity A Tris(1-methylethoxy)phosphane TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001108 |
European Pharmacopoeia |
Buprenorphine Controlled Substance 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001109 |
European Pharmacopoeia |
Buprenorphine hydrochloride Controlled Substance 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001110 |
European Pharmacopoeia |
Gestodene for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001111 |
European Pharmacopoeia |
Ceftazidime for peak identification CRS 2x13mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001112 |
European Pharmacopoeia |
Gestodene 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001113 |
European Pharmacopoeia |
Triolein 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001114 |
European Pharmacopoeia |
Tenoxicam impurity mixture 0.0042mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001115 |
European Pharmacopoeia |
Drospirenone impurity E 3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone) 0.06mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001116 |
European Pharmacopoeia |
Gestodene impurity I 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20-yn-3-one 0.01mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001117 |
European Pharmacopoeia |
Amikacin for system suitability 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001118 |
European Pharmacopoeia |
Vedaprofen impurity mixture TBC |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001119 |
European Pharmacopoeia |
Adapalene for peak identification 2.02mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001120 |
European Pharmacopoeia |
Adapalene impurity C 1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001121 |
European Pharmacopoeia |
Adapalene 100mg |
|
152.32 CHF
165.57 €
|
|
